PL3927315T3 - Preparaty z dodatkiem smakowym - Google Patents

Preparaty z dodatkiem smakowym

Info

Publication number
PL3927315T3
PL3927315T3 PL20714040.1T PL20714040T PL3927315T3 PL 3927315 T3 PL3927315 T3 PL 3927315T3 PL 20714040 T PL20714040 T PL 20714040T PL 3927315 T3 PL3927315 T3 PL 3927315T3
Authority
PL
Poland
Prior art keywords
preparations
added flavor
flavor
added
Prior art date
Application number
PL20714040.1T
Other languages
English (en)
Inventor
Paramjit Singh
Debendra Kumar Panda
Jeffrey Ellis Price
Atul Chhagan BADHAN
Nicholas Finn CUNNINGHAM
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL3927315T3 publication Critical patent/PL3927315T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL20714040.1T 2019-02-20 2020-02-19 Preparaty z dodatkiem smakowym PL3927315T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962807871P 2019-02-20 2019-02-20
PCT/US2020/018762 WO2020172232A1 (en) 2019-02-20 2020-02-19 Palatable formulations

Publications (1)

Publication Number Publication Date
PL3927315T3 true PL3927315T3 (pl) 2026-03-16

Family

ID=69960719

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20714040.1T PL3927315T3 (pl) 2019-02-20 2020-02-19 Preparaty z dodatkiem smakowym

Country Status (26)

Country Link
US (1) US12115162B2 (pl)
EP (2) EP3927315B1 (pl)
JP (1) JP7442540B2 (pl)
KR (1) KR102715939B1 (pl)
CN (1) CN113438941A (pl)
AU (1) AU2020224102C1 (pl)
BR (1) BR112021016480A2 (pl)
CA (1) CA3127621C (pl)
CL (1) CL2021002192A1 (pl)
CO (1) CO2021010698A2 (pl)
DK (1) DK3927315T3 (pl)
EC (1) ECSP21059181A (pl)
ES (1) ES3059915T3 (pl)
FI (1) FI3927315T3 (pl)
HR (1) HRP20260053T1 (pl)
IL (1) IL285078B2 (pl)
LT (1) LT3927315T (pl)
MA (1) MA55027B1 (pl)
MX (1) MX2021010066A (pl)
PH (1) PH12021551859A1 (pl)
PL (1) PL3927315T3 (pl)
PT (1) PT3927315T (pl)
RS (1) RS67643B1 (pl)
UA (1) UA126843C2 (pl)
WO (1) WO2020172232A1 (pl)
ZA (1) ZA202105276B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
US20210068425A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions
EP4507694A1 (en) * 2022-04-15 2025-02-19 KRKA, d.d., Novo mesto Soft chewable veterinary dosage form
JP7355175B1 (ja) 2022-07-25 2023-10-03 フジテック株式会社 エレベータのブレーキ制動能力検査方法及びブレーキ制動能力検査装置
FR3138315A1 (fr) 2022-07-27 2024-02-02 Virbac Produit à usage vétérinaire et procédé pour sa fabrication
WO2024133631A1 (en) * 2022-12-22 2024-06-27 Krka, D.D., Novo Mesto Veterinary composition comprising oclacitinib
WO2024259191A2 (en) * 2023-06-13 2024-12-19 Phoenix Biotechnology, Inc. Method and compositions for treating skin disorders
WO2025207585A1 (en) * 2024-03-25 2025-10-02 Mccloud Josh Environmentally safe moisture activated rodenticide composition and delivery system
CN120346171A (zh) * 2025-03-13 2025-07-22 湖南尚成生物科技有限公司 一种弗雷拉纳咀嚼片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique
WO2003000239A1 (en) 2001-06-21 2003-01-03 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions containing pravastatin
EP2314171B1 (en) 2002-08-13 2019-11-13 Intervet International BV Compositions and process for delivering an additive
US20040037869A1 (en) 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
AR045142A1 (es) 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
RU2007149352A (ru) 2005-06-01 2009-07-20 Хилл`С Пет Ньютришн, Инк. (Us) Способы улучшения вкуса композиций для потребления животным
US7955632B2 (en) * 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20070128251A1 (en) 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
EP2063869B1 (en) 2006-09-07 2014-03-05 Merial Ltd. Soft chewable veterinary antibiotic formulations
CA2733359C (en) 2008-08-20 2014-08-05 Pfizer Inc. Pyrrolo[2,3-d]pyrimidine compounds
JP6290081B2 (ja) 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニFriulchem Spa 動物への経口投与用組成物、その製造方法およびその使用
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US9532946B2 (en) * 2012-11-20 2017-01-03 Intervet Inc. Manufacturing of semi-plastic pharmaceutical dosage units
PL3106150T3 (pl) 2013-12-04 2022-01-03 Boehringer Ingelheim Vetmedica Gmbh Ulepszone kompozycje farmaceutyczne pimobendanu
JP2017533959A (ja) 2014-11-03 2017-11-16 ゾエティス・サービシーズ・エルエルシー 嗜好性が高く咀嚼可能な獣医学的な組成物
US10434061B2 (en) 2014-12-05 2019-10-08 Societe Des Produits Nestle S.A. Composition and method for orally administering one or more active agents to a pet
WO2017106812A1 (en) 2015-12-19 2017-06-22 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations

Also Published As

Publication number Publication date
CO2021010698A2 (es) 2021-08-30
ECSP21059181A (es) 2021-11-30
CN113438941A (zh) 2021-09-24
AU2020224102C1 (en) 2023-03-16
MX2021010066A (es) 2021-09-21
ZA202105276B (en) 2025-04-30
AU2020224102B2 (en) 2022-09-08
CA3127621A1 (en) 2020-08-27
FI3927315T3 (fi) 2026-01-20
EP3927315B1 (en) 2025-11-26
PH12021551859A1 (en) 2022-05-30
US20220062287A1 (en) 2022-03-03
NZ779157A (en) 2023-10-27
US12115162B2 (en) 2024-10-15
RS67643B1 (sr) 2026-02-27
EP4710921A2 (en) 2026-03-18
MA55027A (fr) 2021-12-29
MA55027B1 (fr) 2026-02-27
KR20210114978A (ko) 2021-09-24
EP3927315A1 (en) 2021-12-29
LT3927315T (lt) 2026-02-10
KR102715939B1 (ko) 2024-10-15
AU2020224102A1 (en) 2021-08-19
IL285078A (en) 2021-09-30
JP7442540B2 (ja) 2024-03-04
ES3059915T3 (en) 2026-03-24
BR112021016480A2 (pt) 2021-10-13
WO2020172232A1 (en) 2020-08-27
JP2022521245A (ja) 2022-04-06
CA3127621C (en) 2024-05-14
IL285078B1 (en) 2025-10-01
UA126843C2 (uk) 2023-02-08
CL2021002192A1 (es) 2022-04-01
PT3927315T (pt) 2026-01-29
DK3927315T3 (da) 2026-02-02
IL285078B2 (en) 2026-02-01
HRP20260053T1 (hr) 2026-02-27

Similar Documents

Publication Publication Date Title
PL3927315T3 (pl) Preparaty z dodatkiem smakowym
EP3878518A4 (en) Flavor composition
IL292716A (en) Pro-perfume compositions
EP4069225A4 (en) COMBINATIONS
EP4081071C0 (en) RECLINING CHAIR
HUE061610T2 (hu) Készítmény
DK3737402T5 (da) Modificeret protein
EP3772265C0 (de) Hackvorrichtung
EP4069240A4 (en) ASSOCIATIONS
EP4069241A4 (en) COMBINATIONS
IL286955A (en) Antifungal compositions
EP4083055A4 (en) Sugar-modified protein
DK4064937T3 (da) Møbelsæt
DK3989775T3 (da) Møbel
EP3991538A4 (en) COMBINE HARVESTER
UA41781S (uk) Диван
UA41784S (uk) Диван
UA41783S (uk) Диван
UA41780S (uk) Диван
UA41785S (uk) Диван
UA41782S (uk) Диван
UA41775S (uk) Диван
UA41776S (uk) Диван
UA41774S (uk) Диван
EP4077271C0 (en) BOPTA CALCIUM COMPLEX